Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Folate-chitosan nanoparticles for retinal targeted-delivery of ganciclovir: Preparation, characterization and investigation of their bioactivities.

Created on 15 Nov 2026

Authors

Lidya Agriningsih Haruna, La Ode Muh Julian Purnama, Adryan Fristiohady, Sewan Theeramunkong, Promsin Masrinoul, Jukrapun Komaikul, Kunjimas Ketsuwan, Rathapon Asasutjarit

Published in

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. Pages 115296. Nov 14, 2026. Epub Nov 14, 2026.

Abstract

Herpes simplex virus (HSV)-1-induced retinitis is a serious ocular infection. Although intravitreal (IVT) injection of ganciclovir (GCV) is currently accepted as one of its treatment methods, frequent IVT injection causes some complications. To overcome this limitation, folate-chitosan nanoparticles containing GCV (GCV-FCS-NPs) were prepared. The objectives of this study were 1) to prepare and characterize GCV-FCS-NPs, 2) to evaluate their in vitro bioactivities, and 3) to assess pharmacokinetics of GCV following IVT injection of GCV-FCS-NPs in the rats' eyes. Folate-chitosan was synthesized via a carbodiimide reaction. Then, GCV-FCS-NPs were prepared by an ionic gelation technique. The obtained GCV-FCS-NPs had a particle size of 195 nm with moderate size distribution and positive charges. Their entrapment efficiency was around 21 %. Cellular uptake studies showed that GCV-FCS-NPs could significantly enhance GCV internalization in the ARPE-19 cells. Their IC50 against HSV-1 was 11.75 ± 1.82 µg/mL. Pharmacokinetic studies demonstrated that GCV-FCS-NPs provided higher AUC and longer half-life of GCV in the vitreous humor when compared to that of GCV from GCV solution. Furthermore, IVT injection of GCV-FCS-NPs did not cause harmful side effects in the rats' eyes. These findings indicate the potential of GCV-FCS-NPs for ocular delivery of GCV via IVT injection.

PMID:
43033874
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement